图书简介

Preface; Chapter 1: Drug Delivery, Monitoring and Interactions; Bioavailability of a Drug; Drug Administration Routes; Drug Interactions; Drug Errors; Pharmacogenomics; Neuropharmacology and Critical Care Pharmacology; Chapter 2: Analgosedation and Neuromuscular Blockers; Deciding on Sedation; Sedative Drugs; Analgesics; Neuromuscular Blockers; Neuromuscular Blockers in ICU Practice; Neuromuscular Blockers Reversal; Chapter 3: Agitation and Delirium; Causes of delirium; Clinical Features of Delirium; Pharmacologic Treatment of Agitation; Neuroleptics; Benzodiazepines; Preventive Drugs; Chapter 4: Pain Management; Grading Pain; Types of Pain in the Neurosciences ICU; Indications for Pain Management; Drugs for pain; Non-steroidal Anti-Inflammatory Agents; Patient-controlled Analgesia; Chapter 5: Osmotic Therapy; The Constants of Brain Volume; Hyperosmolar Fluids; Osmotic Agents in Clinical Practice; Chapter 6: Antiepileptic drugs; Seizures in the ICU; Treatment Protocols; Antiepileptic Drugs Used in ICU Practice; Interactions and Adjustments; Chapter 7: Anticoagulation and Reversal Drugs; Anticoagulation and Stroke; Heparin and Warfarin; Factor Xa Inhibitors; Thrombin Inhibitors; Hemorrhage from Anticoagulants; Current Recommendations on Reversal Agents; Chapter 8: Antifibrinolytics and Thrombolytics; Basic Mechanisms and Targets; Antifibrinolytics; Fibrinolytics; Thrombolytics; Post-alteplase Care; Chapter 9: Antiplatelet Agents; Clinical Trials on Antiplatelet Agents in Stroke; Current Indications for Antiplatelet Agents; Antiplatelet Agents; Testing Platelet Function; Antiplatelet Resistance; Discontinuation Antiplatelet Agents before Procedure; Clinical Urgency While on Antiplatelets; Chapter 10: Immunosuppression and Immunotherapy; Corticosteroids; Plasma Exchange; Intravenous Immunoglobulin; Check Point Inhibitor Immunotherapy; Other Therapeutic Targets in Autoimmune Neurology; Chapter 11: Antimicrobial Therapy for CNS infections; Bacterial Meningitis; Viral, Fungal, and Parasitic Infections; The Pharmacology of Antibiotics; Antivirals; Antifungals; Chapter 12: Vasopressors and Inotropes; Mechanisms of Action in Vasopressors and Inotropes; Vasopressors; Inotropes; Use in Clinical Practice; Chapter 13: Antihypertensives and Antiarrhythmics; Definition of Hypertension and Blood Pressure Goals; Best Practice of Antihypertensives; Control of Blood Pressure after Urgent Control; Antiarrhythmic Drugs; Chapter 14: Fluid Therapy; Regulation of Fluid Status; General Principles of Fluid Management; Type of Fluids; Fluid Administration; Fluid Management Principles in the NICU; Acute Fluid Resuscitation; Chapter 15: Drugs to Correct Electrolyte and Acid Base Disorders; Common Electrolyte Replacements; Disorders of Sodium and Water homeostasis; Drugs to manage Sodium Disorders; Chapter 16: Antidotes with Overdose; First Treatment Considerations; Toxins and Major Laboratory Abnormalities; Neurology of Overdose; Commonly Used Agents for Detoxification; Major Toxidromes; Toxic Dysautonomias; Chapter 17: Drugs for Prevention of Complications; Prevention of Deep Venous Thrombosis; Prevention of Hyperglycemia; Prevention of Stress Ulcers; Prevention of Infections; Prevention of Cerebral vasospasm; Chapter 18: Withdrawal Syndromes and Treatment; Alcohol Withdrawal Syndrome; Opioid Withdrawal; Stimulant Withdrawal; Baclofen Withdrawal; Nicotine Withdrawal; Chapter 19: Treatment of Brain Injury-associated Symptoms and Signs; Control of Specific Headaches; Control of Nausea and Vomiting; Control of Hiccups; Control of Secretions; Control of Constipation and Dysmotility; Control of Fever and Shivering; Control of Rhabdomyolysis; Chapter 20: Drugs used in Neurorehabilitation; Neurostimulants; Drugs for post- stroke depression; Drugs for spasticity; Index

Trade Policy 买家须知